Biotest and ADMA Biologics agree to deal for immune globulin

01/14/2013 | HealthcareGlobal.com

Biotest Pharmaceuticals has entered a 10-year deal to act as the exclusive global supplier to ADMA Biologics for respiratory syncytial virus immune globulin made from human plasma. As part of the agreement, ADMA secured the right to use Biotest's proprietary fractionation and purification technology for the production of intravenous immune globulin.

View Full Article in:

HealthcareGlobal.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY